Pathologic Stimulus Determines Lineage Commitment of Cardiac C-kit⁺ Cells.

Area of Science:

• Cardiovascular Biology
• Stem Cell Biology
• Regenerative Medicine

Background:

• Cardiac c-kit⁺ cells are under investigation for cardiac repair, but their in vivo differentiation pathways remain unclear.
• Existing research indicates limited contribution of endogenous cardiac c-kit⁺ cells to the adult cardiomyocyte population.
• Understanding how pathological conditions influence c-kit⁺ cell fate is crucial for therapeutic development.

Purpose of the Study:

• To investigate the differential effects of various pathological stimuli on the lineage differentiation of cardiac c-kit⁺ cells in vivo.
• To elucidate the molecular mechanisms, particularly the role of p53, in c-kit⁺ cell-mediated cardiomyocyte generation.

Main Methods:

• Utilized single-cell sequencing to analyze the heterogeneity of cardiac c-kit⁺ cells.
• Employed genetic lineage tracing to track the fate of c-kit⁺ cells under different pathological conditions.
• Manipulated p53 expression to assess its role in cardiomyocyte differentiation.

Main Results:

• Cardiac c-kit⁺ cells exhibit inherent heterogeneity, comprising vascular and mesenchymal subtypes.
• Pressure overload increased c-kit⁺-derived cardiomyocytes, endothelial cells, and fibroblasts.
• Doxorubicin-induced cardiotoxicity promoted cardiomyocyte differentiation from c-kit⁺ cells, mediated by p53 activation.
• p53 inhibition blocked doxorubicin-induced cardiomyocyte differentiation, while p53 stabilization enhanced it.

Conclusions:

• Pathological stimuli differentially regulate the in vivo cell fates of cardiac c-kit⁺ cells.
• The tumor suppressor p53 plays a critical role in enabling c-kit⁺ cells to differentiate into cardiomyocytes.
• Targeting p53 pathways may offer a strategy to enhance cardiomyocyte generation from c-kit⁺ cells for cardiac repair.